Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -68.14x is in line with its 5-year average of -69.90x, near the high end of its 5-year range (-469.46x–-3.71x).
24.87% above its 12-month average of -90.70x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.71x.
INTEREST COVERAGE RATIO
-68.14x
INTEREST COVERAGE RATIO AVG TTM
-90.70x
INTEREST COVERAGE RATIO AVG 3Y
-44.55x
INTEREST COVERAGE RATIO AVG 5Y
-69.90x
INTEREST COVERAGE RATIO AVG 10Y
-45.86x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+24.87%
CURRENT VS 3Y AVG
-52.95%
CURRENT VS 5Y AVG
+2.52%
CURRENT VS 10Y AVG
-48.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 476 covered companies
CURRENT VS SECTOR MEDIAN
-1076.86%
vs the sector median at left
Allarity Therapeutics, Inc.
Market Cap
$15.72M
Interest Coverage Ratio
-68.14x
TTM Avg
-90.70x
3Y Avg
-44.55x
5Y Avg
-69.90x
Market Cap
$15.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.40M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$15.90M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.75M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.76M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$17.01M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.72M | -68.14x | -90.70x | -44.55x | -69.90x |
| BioCardia, Inc. (BCDA)vs › | $16.04M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -15.67x | 0.81x | 0.81x | 0.81x |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.90M | -1.98x | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -111.88x | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.84M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | N/A | 1.00x | 1.00x | 1.00x |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.57M | -38.62x | N/A | N/A | N/A |
Interest Coverage
-68.1x
Debt/Equity
6.30
Current Ratio
1.11
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.71x |
| 2026-03-31 | -11.74x |
| 2025-12-31 | -49.46x |
| 2025-09-30 | -44.18x |
| 2025-06-30 | -344.42x |
| 2025-03-31 | -53.26x |
| 2024-12-31 | -97.56x |
| 2024-09-30 | -246.26x |
| 2024-06-30 | -7.91x |
| 2024-03-31 | -41.57x |
| 2023-12-31 | -21.21x |
| 2023-09-30 | -130.18x |
| 2023-06-30 | -29.27x |
| 2023-03-31 | -39.87x |
| 2022-12-31 | -58.19x |
| 2022-09-30 | -130.34x |
| 2022-06-30 | -146.73x |
| 2022-03-31 | -469.46x |
| 2021-12-31 | -61.64x |
| 2021-09-30 | -147.19x |
| 2021-06-30 | -7.83x |
| 2021-03-31 | -14.83x |
| 2020-12-31 | -81.67x |
| 2020-09-30 | -72.42x |
| 2019-12-31 | -11.45x |
| 2019-09-30 | -3.25x |
| 2019-06-30 | -1.56x |
| 2019-03-31 | -6.21x |
| 2018-12-31 | -37.55x |
| 2018-09-30 | -21.03x |
| 2018-03-31 | -4.00x |
| 2017-09-30 | -2.85x |
| 2017-06-30 | -0.78x |
| 2017-03-31 | -81.34x |
| 2016-12-31 | -46.68x |
| 2016-09-30 | -551.74x |
| 2016-03-31 | -71.61x |
| 2015-12-31 | -21.85x |
